Neo-checkray biomarkers : TILs and PD-L1 Early Dynamics in the NEO-CHECKRAY Phase II Trial evaluating Immuno-Radiation and Adenosine Pathway Blockade for Early-Stage, High Risk, ER+/HER2- Breast Cancer

De Caluwe, Alex;Catteau, Xavier;van Marcke de Lummen, Cedric Jacques;Buisseret, Laurence;et.al.
(2024) ESMO IMMUNO-ONCOLOGY 2024 — Location: Geneva, Switzerland (11.December.2024)

Files

No attached file found for this publication.

Details

Authors
Abstract
no abstract available
Affiliations

Citations

  • APA
  • Chicago
  • FWB

De Caluwe, A., Catteau, X., van Marcke de Lummen, C. J., Buisseret, L., & et al. (2024). Neo-checkray biomarkers : TILs and PD-L1 Early Dynamics in the NEO-CHECKRAY Phase II Trial evaluating Immuno-Radiation and Adenosine Pathway Blockade for Early-Stage, High Risk, ER+/HER2- Breast Cancer. ESMO IMMUNO-ONCOLOGY 2024, Geneva, Switzerland. https://hdl.handle.net/2078.5/235756